Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Clinical study proves benefits of joint supplements on canine mobility
Dr Matthew Pead and Dr John Howie at the BSAVA congress.
Dr Matthew Pead and Dr John Howie at the BSAVA congress.

Royal Veterinary College study found "significant" improvements over six week period

The Royal Veterinary College says it has found the first ever clinical proof of the effect of joint supplements on canine mobility.

The college carried out a two and a half year long clinical study.

Monitors originally developed to track wild cat movements in Africa were instead applied to measure the activity of dogs over a six week period.

One set of dogs were given the YUMOVE supplement, and another group a placebo. The group that were given YUMOVE showed statistically significant improvements , the college said.

"This study represents a major step forward in canine mobility”, said Dr Matthew Pead, lead investigator at the RVC.

“It took nine months of careful planning to ensure a robust methodology was developed to provide clear clinical results that veterinary professionals can rely on, and give confidence when recommending joint supplements to dog owners.

"Furthermore, the huge volume of objective activity data will enhance our understanding of the effect of canine osteoarthritis on mobility and activity in the dog’s day to day activities.”

The clinical study was sponsored by Lintbells, the UK based manufacturer of YUMOVE.

“We are very excited by the results of the clinical study” said Lintbells co-founder Dr John Howie.

“From the extensive feedback from owners and vets alike, we already knew the product worked.

"But we wanted to establish independent, rigorous clinical evidence for YUMOVE so that veterinary professionals could recommend the product with confidence, and dog owners knew what to expect from a clinically proven joint supplement in real-life situations.

"There is a great deal of uncertainty and confusion when it comes to joint supplements. This clinical study now provides clarity for clinician and owner alike.

"With an estimated 1.2 million dogs suffering from joint and mobility issues and only approximately 10 to 15 per cent receiving a nutritional supplement, Lintbells believes that providing an affordable, proven product that owners can rely on will uncap the significant market opportunity for veterinary professionals.”

 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.